You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

Citation Tools

Article menu

Download PDFPDF

Treatments
Original article
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Liang H, Danwada R, Guo D, et al
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
RMD Open 2019;5:e001013. doi: 10.1136/rmdopen-2019-001013